Name: Boric acid
SKU: 10043-35-3

Products Categories

Pharmaceutical (24)
Organic Chemicals (19)
Others (10)
Catalyst and Auxiliary (3)
Basic Inorganic Chemicals (2)
Agrochemicals (1)
Synthetic Flavours & Fragrances (1)

Basic Information

Molecular Structure:
CAS No.:	10043-35-3
Name:	Boric acid

Formula:	BH₃O₃
Molecular Weight:	61.833
Synonyms:	Boracic acid;Boron trihydroxide;
EINECS:	233-139-2
Density:	1.438 g/cm³
Melting Point:	169 °C
Boiling Point:	219-220 °C (9.7513 mmHg)
Solubility:	49.5 g/L (20 °C) in water
Appearance:	white crystalline solid
Hazard Symbols:	Xi,T,Xn
Risk Codes:	36/37/38-60-63-62
Safety:	26-36-53-45-37/39-36/37/39-22
PSA:	60.69000
LogP:	-2.05180

Country:
- China (Mainland)(31)
- United States(1)
Business Type:
All

Lab/Research institutions

Trading Company

Manufacturers

Other
Certificate:
Manufacturer

Enterprise Authentication

ISO

GMP

FDA

HALAL

Display:default sort
Suppiers of more reward points first

New supplier

Total:32 Page 1 of 1 1

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 10043-35-3

Specification

The IUPAC name of OrthoOrthoboric acid is Orthoboric acid. With the CAS registry number 10043-35-3, it is also named as Boron hydroxide. The product's categories are Industrial/Fine Chemicals; Inorganics; BI - BZSpectroscopy; AAS; AAS CRMsAlphabetic; AASSpectroscopy; Application CRMs; B; Matrix Selection; Nitrate; Spectroscopy; Buffers A to ZBiological Buffers; SigmaUltra Buffers; Biological Buffers; Buffer Convenience Packaging; Buffer TabletsBiological Buffers; A-B, Puriss p.a. ACS; Analytical Reagents for General Use; Puriss p.a. ACS; Buffers A to Z; AlphabeticalMolecular Biology; BioUltra Buffers; etc., and the other registry numbers are 12795-04-9; 30698-98-7. Besides, it is white crystalline solid, which should be stored in dry, clean, cool and ventilated warehouse. In addition, its molecular formula is H₃BO₃ and molecular weight is 61.83.

The other characteristics of this product can be summarized as: (1)EINECS: 201-191-5; (2)# of Rule of 5 Violations: 0; (3)ACD/BCF (pH 5.5): 1; (4)ACD/BCF (pH 7.4): 1; (5)ACD/KOC (pH 5.5):; (6)ACD/KOC (pH 7.4):; (7)#H bond acceptors: 3; (8)#H bond donors: 3; (9)#Freely Rotating Bonds: 3; (10)Polar Surface Area: 60.69 Å²; (11)Index of Refraction: 1.385; (12)Molar Refractivity: 10.083 cm³; (13)Molar Volume: 43.003 cm³; (14)Polarizability: 3.997×10^-24cm³; (15)Surface Tension: 59.198 dyne/cm; (16)Density: 1.438 g/cm³; (17)Melting point: 169 °C; (18)Boiling point: 300 °C; (19)Water solubility: 49.5 g/L (20 °C); (20)Vapor pressure: 2.6 mm Hg ( 20 °C).

Preparation of OrthoOrthoboric acid: this chemical can be prepared by the reaction of Sodium tetraborate decahydrate with Hydrochloric acid:
Na₂B₄O₇^.10H₂O + 2 HCl → 4 B(OH)₃ + 2 NaCl + 5 H₂O

Uses of OrthoOrthoboric acid: this chemical is used for minor burns or cuts as an antiseptic. It is also used for acne treatment as an anti-bacterial. Its buffer is widely used for the electrophoresis of nucleic acids. What's more, it can be used as an insecticide to prevent and destroy existing wet and dry rot in timbers. It also can be used to lubricate carrom boards. It is mainly used for the manufacture of monofilament fiberglass usually referred to as textile fiberglass in industry. And it is used as a neutron poison to slow down the rate at which fission is occurring in nuclear power plants. Furthermore, it is often used to reduce surface oxidation and firescale from forming on metals during annealing and soldering operations in combination with denatured alcohol. It is also used in the production of the glass in LCD flat panel displays.

When you are using this chemical, please be cautious about it as the following: it is irritating to eyes, respiratory system and skin. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. And you should wear suitable protective clothing, gloves and eye/face protection. Moreover, it is risk of impaired fertility. It is also possible risk of harm to the unborn child. Please do not breathe dust. And avoid exposure - obtain special instructions before use. Additionally, in case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)

People can use the following data to convert to the molecule structure.
(1)Canonical SMILES: B(O)(O)O
(2)InChI: InChI=1S/BH3O3/c2-1(3)4/h2-4H
(3)InChIKey: KGBXLFKZBHKPEV-UHFFFAOYSA-N

The toxicity data is as follows:

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
child	LDLo	skin	1500mg/kg (1500mg/kg)	SENSE ORGANS AND SPECIAL SENSES: CONJUNCTIVE IRRITATION: EYE LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"	Quarterly Journal of Pharmacy & Pharmacology. Vol. 6, Pg. 714, 1933.
child	LDLo	skin	4gm/kg/4D (4000mg/kg)		Muenchener Medicinische Wochenschrift. Vol. 52, Pg. 763, 1905.
child	TDLo	oral	500mg/kg (500mg/kg)	GASTROINTESTINAL: NAUSEA OR VOMITING	Journal of Toxicology, Clinical Toxicology. Vol. 24, Pg. 269, 1986.
dog	LDLo	oral	1780mg/kg (1780mg/kg)	BRAIN AND COVERINGS: MENINGEAL CHANGES LUNGS, THORAX, OR RESPIRATION: CYANOSIS GASTROINTESTINAL: NAUSEA OR VOMITING	JAMA, Journal of the American Medical Association. Vol. 128, Pg. 266, 1945.
dog	LDLo	parenteral	1gm/kg (1000mg/kg)	PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)	Rassegna di Terapia e Patologia Clinica. Vol. 1, Pg. 472, 1929.
dog	LDLo	subcutaneous	1gm/kg (1000mg/kg)	BRAIN AND COVERINGS: MENINGEAL CHANGES LUNGS, THORAX, OR RESPIRATION: CYANOSIS GASTROINTESTINAL: NAUSEA OR VOMITING	JAMA, Journal of the American Medical Association. Vol. 128, Pg. 266, 1945.
guinea pig	LD50	subcutaneous	1200mg/kg (1200mg/kg)	BEHAVIORAL: TREMOR GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" GASTROINTESTINAL: NAUSEA OR VOMITING	U.S. Army, Chemical Corps Medical Division Special Report. Vol. #2, Pg. 1950,
guinea pig	LDLo	oral	1gm/kg (1000mg/kg)	GASTROINTESTINAL: NAUSEA OR VOMITING GASTROINTESTINAL: OTHER CHANGES	Revista de la Asociacion Medica Argentina. Vol. 46, Pg. 1493, 1932.
infant	LDLo	oral	934mg/kg (934mg/kg)		JAMA, Journal of the American Medical Association. Vol. 90, Pg. 382, 1928.
infant	LDLo	skin	1200mg/kg (1200mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"	JAMA, Journal of the American Medical Association. Vol. 129, Pg. 332, 1945.
infant	LDLo	subcutaneous	1100mg/kg (1100mg/kg)	BEHAVIORAL: TREMOR GASTROINTESTINAL: NAUSEA OR VOMITING GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"	U.S. Army, Chemical Corps Medical Division Special Report. Vol. #2, Pg. 1950,
infant	TDLo	oral	800mg/kg/4W-I (800mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" GASTROINTESTINAL: NAUSEA OR VOMITING	Archives of Disease in Childhood. Vol. 58, Pg. 737, 1983.
man	LDLo	oral	429mg/kg (429mg/kg)	CARDIAC: OTHER CHANGES KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)"	Journal of Toxicology, Clinical Toxicology. Vol. 31, Pg. 345, 1993.
man	LDLo	skin	2430mg/kg (2430mg/kg)	GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" SKIN AND APPENDAGES (SKIN): PRIMARY IRRITATION: AFTER TOPICAL EXPOSURE	JAMA, Journal of the American Medical Association. Vol. 128, Pg. 266, 1945.
man	LDLo	unreported	147mg/kg (147mg/kg)		"Poisoning; Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970Vol. 2, Pg. 73, 1970.
man	TDLo	unreported	170mg/kg (170mg/kg)	BEHAVIORAL: WAKEFULNESS BEHAVIORAL: ANOREXIA (HUMAN GASTROINTESTINAL: NAUSEA OR VOMITING	Rassegna di Terapia e Patologia Clinica. Vol. 1, Pg. 472, 1929.
mouse	LD50	intravenous	1240mg/kg (1240mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Journal of Pharmacology and Experimental Therapeutics. Vol. 134, Pg. 117, 1961.
mouse	LD50	oral	3450mg/kg (3450mg/kg)		JAMA, Journal of the American Medical Association. Vol. 128, Pg. 266, 1945.
mouse	LD50	subcutaneous	1740mg/kg (1740mg/kg)		JAMA, Journal of the American Medical Association. Vol. 128, Pg. 266, 1945.
mouse	LDLo	intraperitoneal	800mg/kg (800mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: ATAXIA	"Boron, Metallo-Boron Compounds and Boranes," Adams, R.M., ed., New York, John Wiley & Sons, Inc., 1964Vol. -, Pg. 693, 1964.
rabbit	LDLo	intravenous	800mg/kg (800mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: ATAXIA	"Boron, Metallo-Boron Compounds and Boranes," Adams, R.M., ed., New York, John Wiley & Sons, Inc., 1964Vol. -, Pg. 693, 1964.
rabbit	LDLo	oral	4gm/kg (4000mg/kg)	BEHAVIORAL: TREMOR GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" GASTROINTESTINAL: NAUSEA OR VOMITING	U.S. Army, Chemical Corps Medical Division Special Report. Vol. #2, Pg. 1950,
rabbit	LDLo	parenteral	670mg/kg (670mg/kg)		Rassegna di Terapia e Patologia Clinica. Vol. 1, Pg. 472, 1929.
rabbit	LDLo	subcutaneous	150mg/kg (150mg/kg)		"Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1289, 1935.
rat	LCLo	inhalation	28mg/m³/4H (28mg/m³)		"Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982Vol. -, Pg. 27, 1982.
rat	LD50	intravenous	1330mg/kg (1330mg/kg)	BEHAVIORAL: TREMOR GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" GASTROINTESTINAL: NAUSEA OR VOMITING	U.S. Army, Chemical Corps Medical Division Special Report. Vol. #2, Pg. 1950,
rat	LD50	oral	2660mg/kg (2660mg/kg)		JAMA, Journal of the American Medical Association. Vol. 128, Pg. 266, 1945.
rat	LD50	subcutaneous	1400mg/kg (1400mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: ATAXIA	"Boron, Metallo-Boron Compounds and Boranes," Adams, R.M., ed., New York, John Wiley & Sons, Inc., 1964Vol. -, Pg. 693, 1964.
women	LDLo	oral	200mg/kg (200mg/kg)	BEHAVIORAL: FLUID INTAKE GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" GASTROINTESTINAL: NAUSEA OR VOMITING	Lancet. Vol. 2, Pg. 162, 1917.
women	TDLo	oral	400mg/kg (400mg/kg)	GASTROINTESTINAL: NAUSEA OR VOMITING GASTROINTESTINAL: OTHER CHANGES SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"	Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 32, Pg. 804, 1990.

Products

10043-35-3

Refine

Country

Business Type

Certificate

Display

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

10043-35-3

Specification